Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Riesterer, O; Matsumoto, F; Wang, L; Pickett, J; Molkentine, D; Giri, U; Milas, L; Raju, U (2011). A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe. Investigational New Drugs, 29(3):514-522.

Torres, M A; Raju, U; Molkentine, D; Riesterer, O; Milas, L; Ang, K K (2011). AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo. Investigational New Drugs, 29(4):554-561.

Riesterer, O; Yang, Q; Raju, U; Torres, M; Molkentine, D; Patel, N; Valdecanas, D; Milas, L; Ang, K K (2011). Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers. International Journal of Radiation Oncology, Biology and Physics, 79(4):1179-1187.

Koto, M; Choi, H; Riesterer, O; Giri, U; Story, M D; Ha, C S; Raju, U (2011). Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitro. Anticancer Research, 31(1):33-38.

Skvortsova, I; Skvortsov, S; Raju, U; Stasyk, T; Riesterer, O; Schottdorf, E-M; Popper, B-A; Schiestl, B; Eichberger, P; Debbage, P; Neher, A; Bonn, G K; Huber, L A; Milas, L; Lukas, P (2010). Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. Radiotherapy and Oncology, 96(1):108-115.

Riesterer, O; Mason, K A; Raju, U; Yang, Q; Wang, L; Hittelman, W N; Ang, K K; Milas, L (2009). Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed. Radiotherapy and Oncology, 92(3):383-387.

Cho, H; Koto, M; Riesterer, O; Molkentine, D P; Giri, U; Milas, L; Story, M D; Ha, C S; Raju, U (2009). Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study. Anticancer Research, 29(11):4409-4415.

This list was generated on Sun Nov 18 17:07:36 2018 CET.